CD34+-selected autologous peripheral blood stem cell transplantation (PBSCT) in patients with poor-risk hematological malignancies and solid tumors. A single-centre experience

Bone Marrow Transplantation

Volumn 20, Issue 10, 1997, Pages 827-834

  Nachbaur, D ^a,c   Fink, F M ^b   Nussbaumer, W ^b   Gachter A ^a   Kropshofer, G ^a   Ludescher, C ^b   Niederwieser, D ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

CD34+ selection; Hematological malignancies; Peripheral blood stem cell transplantation; Solid tumors

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LEUKOCYTE; MALE; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SOLID TUMOR; STEM CELL TRANSPLANTATION; THROMBOCYTE;

EID: 0030730464     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700981     Document Type: Article

References (30)

1. Brunvand MW, Bensinger WI, Soll E et al. High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells. Bone Marrow Transplant 1996; 18: 131-141.
2. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547-2555.
3. Langenmayer I, Weaver C, Buckner CD et al. Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both. Bone Marrow Transplant 1995; 15: 241-246.
4. Bensinger WI, Rowley SD, Demirer T et al. High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma. J Clin Oncol 1996; 14: 1447-1456.
5. Weaver CH, Petersen FB, Appelbaum FR et al. High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma. J Clin Oncol 1994; 12: 2559-2566.
6. Elias AD, Ayash L, Anderson KC et al. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 1993; 79: 3036-3044.
7. Fukuda M, Kojima S, Matsumoto K, Matsuyama T. Autotransplantation of peripheral blood stem cells mobilized by chemotherapy and recombinant human granulocyte colony-stimulating factor in childhood neuroblastoma. Br J Haematol 1992; 80: 327-331.
8. To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1991; 9: 277-284.
9. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068-3076.
10. Brenner MK. Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancer 1993; 341: 85-86.
11. Rill DR, Santana VM, Roberts WM et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 1994; 84: 380-383.
12. Brugger W, Bross KJ, Glatt M et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994; 83: 636-640.
13. Ross AA, Cooper BW, Lazarus HM et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 1993; 82: 2605-2610.
14. + cells to remove circulating tumor cells. Blood 1996; 87: 1625-1634.
15. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 86: 390-397.
16. Shpall EJ, Jones RB, Bearman SI et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 1994; 12: 28-36.
17. Kaplan E, Meier P. Non-parametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
18. Brown BW. Hollander M. Linear regression and correlation. In: Brown B, Hollander M (eds). Statistics. Wiley: New York, 1977, pp 261-307.
19. Sachs L. Angewandte Statistik. Springer Verlag: Berlin, 1974.
20. Tricot G, Jagannath S, Vesole D et al. Peripheral blood stem cell transplants for multiple myeloma: identification for favorable variables for rapid engraftment in 225 patients. Blood 1995; 85: 588-596.
21. Dreger P, Klöss M, Petersen B et al. Autologous progenitor cell transplantation: prior exposure to stem cell toxic drugs determines the yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 1995; 86: 3970-3978.
22. De Fabritiis P, Sandrelli A, Meloni G et al. Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autografting. Bone Marrow Transplant 1990; 6: 247-251.
23. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 1994; 84: 1421-1426.
24. + cell content. Bone Marrow Transplant 1997; 19: 1103-1110.
25. + myeloma cells. Br J Haematol 1996; 93: 613-622.
26. Widmer L, Pichert G, Jost LM, Stahel RA. Fate of contaminating t(14;18)+ Iymphoma cells during ex vivo expansion of CD34-selected hematopoietic progenitor cells. Blood 1996; 88: 3166-3175.
27. + blood cells. Br J Haematol 1996; 94: 716-721.
28. + marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons. Blood 1992; 80: 1693-1701.
29. Pirsch JD, Maki DG. Infectious complication in adults with bone marrow transplantation and T cell depletion of donor marrow. Increased susceptibility to fungal infections. Ann Intern Med 1986; 104: 619-631.
30. Nachbaur D, Kropshofer G, Feichtinger H et al. Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin and recombinant human interleukin-2. Bone Marrow Transplant 1997; 19: 1261-1263.